Interestingly, epigallocatechin-3-gallate (EGCG) supplementation at a dosage of 300 mg/day for 8 weeks significantly decreased the level of FBG, CRP levels, and body mass index compared to the baseline among 50 patients with T2DM [221]. This evidence concerns the gene CRP and type 2 diabetes mellitus.